PATENT CLAIM ANALYSIS

Application Number: 15876827
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["705", "002000"]

Abstract:
Embodiments of the present disclosure relate to a drug monitoring tool. The drug monitoring tool comprises a data receiver and an interactive user interface. The data receiver is configured to receive a pharmacokinetic (PK) profile of a patient. The interactive user interface is configured to display, to the patient, a time-varying therapeutic plasma protein level of the patient. The time-varying therapeutic plasma protein level is based on an administered dose of a clotting factor VIII and the PK profile of the patient.

Claim (Index 21):
A drug monitoring system, the system comprising:\n a therapeutic plasma protein dosing regimen apparatus comprising:\n a model generator configured to create a Bayesian model of pharmacokinetic (PK) profiles of sampled patients, the Bayesian model including (i) a therapeutic plasma protein clearance and (ii) a volume of distribution relationship for a therapeutic plasma protein based upon at least one of patient age or body weight, and \n a PK server configured to:\n determine an approximate PK profile of a patient based upon the Bayesian model, a half-life of the therapeutic plasma protein within the patient, and at least one of an age of the patient or a weight of the patient, \n determine the therapeutic plasma protein dosing regimen including a dosage and a therapeutic plasma protein level over a time period based upon the approximate PK profile of the patient, \n modify the therapeutic plasma protein dosing regimen in response to receiving a dosing interval for applying a dosage to the patient, and \n transmit the modified therapeutic plasma protein dosing regimen to the client device; and \n \n a drug monitoring tool comprising: \n a data receiver configured to receive the pharmacokinetic (PK) profile of a patient, and \n an interactive user interface configured to display to the patient a time-varying therapeutic plasma protein level of the patient, the time-varying therapeutic plasma protein level based on an administered dose of a clotting factor VIII and the PK profile of the patient.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 86.0
- Lexical Diversity: 2.06818
- Patent Class: 705.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15101756', '14416214', '14411362', '14234789', '13513424']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.1071507198554163
- 35 USC 102 Novelty (BERT): 0.5176550769462563
- Combined Prediction Score: 0.1482011555645003
- Mean Citation Score: 240.832788
- Max Citation Score: 320.1036
- Similarity Product: 222.5354777438164

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test